Abstract Thailand is encountering challenges to introduce the high-cost sofosbuvir for chronic hepatitis C treatment as part of the Universal Health Care’s benefit package. This study was conducted in respond to policy demand from the Thai government to assess the value for money and budget impac

Reviewing the evidence on effectiveness and cost-effectiveness of HIV prevention strategies in Thailand. Pattanaphesaj J, Teerawattananon Y.  Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Thailand Backgroud: Following universal access to antiretroviral

Abstract The role of Health Technology Assessment (HTA) is evolving. Once seen primarily as a gatekeeper, HTA is increasingly viewed as a potential shaper of health system transformation. The first plenary session of the HTA International 2025 Annual Meeting, explored the potential for HTA to ado

This was the presentation made to consult with experts from the UK during a visit by Dr. Paramjit Gill, Reader in Primary Care Research and Dr. Rachel Foskett-Tharby, Research Fellow National Collaborating Centre for Indicator Development (NCCID), Primary Care Clinical Sciences, University of Bi

The researchers would like to acknowledge the help, contribution, and support of the stakeholders and partners who participated during our proposal development, diseases prioritization process and in-depth interviews, including government officers/decision-makers, healthcare providers, academi